PD-1/PD-L1-IN-52
PD-1/PD-L1-IN-52 (Compound III-5) is an orally active PD-1/PD-L1 inhibitor that blocks the interaction between PD-1 and PD-L1, with an IC50 of 109.9 nM. PD-1/PD-L1-IN-52 exhibits antitumor activity in a C57BL/6 mouse xenograft model implanted with human PD-1-expressing MC38 colon cancer cells, with a TGI of 49.6%[1].
Product Specifications
CAS Number
[2856391-46-1]
UNSPSC
12352005
Target
PD-1/PD-L1
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pd-1-pd-l1-in-52.html
Smiles
OC[C@H](C(OCC)=O)NCC1=CC(Cl)=C(OCC2=C(C)C(C3=CC=CC(OCCCN4N=NC(CN[C@@H](C(OCC)=O)CO)=C4)=C3C)=CC=C2)C=C1OCC5=CC(C#N)=CN=C5
Molecular Formula
C45H52ClN7O9
Molecular Weight
870.39
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Chlorobium limicola 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr)
Recombinant Chlorobium limicola 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr)
Recombinant Chlorobium limicola 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr)
Recombinant Chlorobium limicola 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr)
Recombinant Chlorobium limicola 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr)